Twist Bioscience Corp (NAS:TWST)
$ 42.23 0.87 (2.1%) Market Cap: 2.46 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 4.38 GF Score: 83/100

Twist Bioscience Corp at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 03:20PM GMT
Release Date Price: $125.03 (+18.53%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Okay. I think that's it. Again, this is Luke Sergott. I work at Barclays, cover the life science tools and diagnostics space. And it's my pleasure to have Emily Leproust, and Jim Thorburn and Angela Bitting with me from Twist Biosciences. They are the -- one of the major synbio players here. And give great color on the industry and everything else you want to -- could possibly want to know about writing DNA. So with that, I'll allow them to introduce, provide a brief overview, and then we can dig in.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman, President & CEO

I -- Luke, you want me to show some slides?

Luke England Sergott;Emily Marine Leproust
Barclays Bank PLC, Research Division - Research Analyst;Twist Bioscience Corporation - Co-Founder, Chairman,

If you want me -- if you want to, that would be great. So just go ahead and share your screen, and I'll turn off my video.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot